John Kaufman

Overview

AstraZeneca platform development and digital transformation lead for drug substance development, champion of FAIR data, AI interoperability standards, continuous processing, and 80/20 automation philosophy John Kaufman leads platform development for new molecules at AstraZeneca and took on a digital transformation role for drug substance development in October 2025, making data FAIR his primary focus. Kaufman identifies non-interoperability of data and AI systems as the most critical blocker to AI adoption, arguing that equipment and software from different vendors must automatically exchange data and AI commands like a Star Wars C3PO translator droid. (Segment 2 (05:00-10:00))